Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

NCT00637663

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pusan National University School of Medicine Busan, South Korea

Severance Hospital Seoul, South Korea

View Trial Details

Completed

Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

NCT01134952

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: London Health Sciences Centre London, Ontario, Canada

View Trial Details

Completed

Evaluation of Rapid Virologic Response Among HCV Patients Treated With PegIntron and Rebetol in Brazil (Study P05427)

NCT00724854

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Bioequivalence Study of Daclatasvir Tablets and Bioavailability Studies of Daclatasvir and Asunaprevir

NCT02323594

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B

NCT02366208

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: 302 Military Hoapital of China Beijing, Beijing Municipality, China

Hainan General Hospital Haikou, Hainan, China

The Third Hospital of Hebei Medical University Shijiazhuang, Hebei, China

The Second Xiangya Hospital of Central South University Changsha, Hunan, China

View Trial Details

Completed

Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)

NCT00736242

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +24 more
Locations: Not specified

View Trial Details

Completed

Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis

NCT02331589

Conditions: Chronic Disease, Digestive System Diseases, Disease Attributes, +9 more
Locations: Not specified

View Trial Details

Completed

Study of Drug Combination on Pharmacokinetics in Healthy Volunteers

NCT02175602

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

NCT01081158

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Not specified

View Trial Details

Completed

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

NCT01466790

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Hoover, Alabama, United States

Bakersfield, California, United States

La Jolla, California, United States

San Diego, California, United States

View all 23 locations

View Trial Details